邹纯才, 鄢海燕, 王莉丽, 卞莹莹. 瓜蒌提取物抗血栓药效成分群的筛选与验证J. 药学学报, 2019,54(3): 502-509. doi: 10.16438/j.0513-4870.2018-0898
引用本文: 邹纯才, 鄢海燕, 王莉丽, 卞莹莹. 瓜蒌提取物抗血栓药效成分群的筛选与验证J. 药学学报, 2019,54(3): 502-509. doi: 10.16438/j.0513-4870.2018-0898
ZOU Chun-cai, YAN Hai-yan, WANG Li-li, BIAN Ying-ying. Screening and validation of antithrombotic effective components group from Trichosanthes extractJ. Acta Pharmaceutica Sinica, 2019,54(3): 502-509. doi: 10.16438/j.0513-4870.2018-0898
Citation: ZOU Chun-cai, YAN Hai-yan, WANG Li-li, BIAN Ying-ying. Screening and validation of antithrombotic effective components group from Trichosanthes extractJ. Acta Pharmaceutica Sinica, 2019,54(3): 502-509. doi: 10.16438/j.0513-4870.2018-0898

瓜蒌提取物抗血栓药效成分群的筛选与验证

Screening and validation of antithrombotic effective components group from Trichosanthes extract

  • 摘要: 筛选瓜蒌提取物抗血栓的药效成分群并进行药效学验证与作用机制分析。建立瓜蒌提取物的HPLC指纹图谱,以阿司匹林(0.01 g·kg-1)为阳性对照组,测定瓜蒌提取物(0.09、0.45和0.9 g·kg-1)抗大鼠血栓药效学指标(本实验所用动物经皖南医学院医学伦理委员会批准同意),采用灰色关联度法研究瓜蒌提取物抗血栓的谱效关系并筛选药效成分群。按药效成分群中各成分的含量制备单体化合物混合溶液(0.006、0.03和0.06 g·kg-1)并进行药效学和作用机制研究,以验证谱效关系结果的正确性。瓜蒌提取物22个成分与抗血栓药效间的关联度呈量效关系且关联度不同。胞嘧啶、尿嘧啶、鸟嘌呤、次黄嘌呤、黄嘌呤、腺嘌呤、鸟苷和腺苷8个成分是瓜蒌提取物抗血栓的主要药效成分群,这些成分比例为3:12:10:5:2:8:13:14。药效成分群各组与模型组比较均可有效降低血栓干重(P<0.01或P<0.05),但与瓜蒌提取物组(0.45 g·kg-1)比较无统计学意义。与模型组比较,药效成分群0.06 g·kg-1组和0.03 g·kg-1组均可有效降低TXB2含量(P<0.01或P<0.05),药效成分群各组均可升高6-keto-PGF1α含量(P<0.01),改善TXB2/6-keto-PGF1α趋于正常且呈量效关系,此效果优于瓜蒌提取物组(0.45 g·kg-1)(P<0.01)。药效成分群有较好的抗血栓作用,其作用机制为抑制血小板聚集及改善血管内皮功能。

     

    Abstract: To screen the antithrombotic effective components group of Trichosanthes extract, and to verify its pharmacodynamics and analyze its mechanism, the HPLC fingerprint of Trichosanthes extract (0.09, 0.45, 0.9 g·kg-1) was established, and the pharmacodynamic indexes of antithrombosis in rats with aspirin (0.01 g·kg-1) as positive control group were determined (the animals used in this experiment were approved by the Medical Ethics Committee of Wannan Medical College). The antithrombotic spectrum-activity relationship of Trichosanthes extract was studied and the effective antithrombotic ingredients group was screened by grey relational analysis. The monomer compound mixed solution (0.006, 0.03, 0.06 g·kg-1) was prepared according to the content of each component in the active component group, and the pharmacodynamics and action mechanism were studied to verify the correctness of the spectrum-effect relationship. The correlation between the 22 components of Trichosanthes extract and antithrombotic efficacy was different and showed dose-effect relationship. Cytosine, uracil, guanine, hypoxanthine, xanthine, adenine, guanosine, and adenosine are the main antithrombotic components of Trichosanthes extract. The ratio of cytosine, uracil, guanine, hypoxanthine, xanthine, adenine, guanosine and adenosine was 3:12:10:5:2:8:13:14. Compared with the model group, the thrombus dry weight of each effective components group could be effectively reduced (P<0.01 or P<0.05), but there was no significant difference between each effective components group and the Trichosanthes extract group. Compared with the model group, the TXB2 content in group (0.06 g·kg-1, 0.03 g·kg-1) could be effectively reduced (P<0.01 or P<0.05), and the content of 6-keto-PGF1α could be increased in each group (P<0.01), and the TXB2/6-keto-PGF1α tended to be normal and showed a dose-effect relationship. The effect was better than that in the Trichosanthes extract group (0.45 g·kg-1) (P<0.01). The effective ingredients group has a good antithrombotic effect, its mechanism is to inhibit platelet aggregation and improve vascular endothelial function.

     

/

返回文章
返回